Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 9, 2001, Pages 1440-1445

  Silence, J ^a   Lupu, F ^b   Collen, D ^a   Lijnen, H R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Aneurysm; Apolipoprotein E; Atherosclerosis; Matrix metalloproteinases; Stromelysin 1

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; COLLAGEN; PLASMIN; STROMELYSIN; UROKINASE;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE INACTIVATION; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THORACIC AORTA ANEURYSM;

EID: 0035572899     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0901.097004     Document Type: Article

References (37)

1. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage and smooth muscle cell content
2. Atherosclerosis: An inflammatory disease
3. Cellular localization of matrix metalloproteinase in the abdominal aortic aneurysm wall
4. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms
5. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall: A possible mechanism for aneurysm expansion
6. Plasminogen activator expression in human atherosclerotic lesions
7. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
8. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization
9. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions
10. Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo
11. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: Evidence for activation by proinflammatory mediators
12. Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: A potential protective mechanism in plaque stability
13. Urokinase-generated plasmin is a candidate activator of matrix metalloproteinases during atherosclerotic aneurysm formation
14. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice
15. Local overexpresision of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model
16. Matrix metalloproteinases and their inhibitors
17. Matrix metalloproteinase system deficiencies and matrix degradation
18. Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice
19. Susceptibility of stromelysin-1 deficient mice to collagen-induced arthritis and cartilage destruction
20. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
21. Guidelines for the use of animals in biomedical research
22. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
23. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice
24. Molecular basis of the acute coronary syndromes
25. Pathogenesis of aneurysms
26. Current views on the pathogenesis of abdominal aortic aneurysms
27. Matrix metalloproteinases and cardiovascular disease
28. Demonstration of interstitial collagenase in abdominal aortic aneurysm disease
29. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms
30. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease
31. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms
32. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1
33. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice
34. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse
35. Pathology of atheromatous lesions in inbred and genetically engineered mice: Genetic determination of arterial calcification
36. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter, which results in reduced gene expression
37. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms